The result of relatively large dose of 5% sodiummorrhuateinjection (SMI) in the treatment of 590 cases in the cavernous hemangioma in oro-facial region is presented.
Methods: 64 cases were allocated to 2 groups randomly, 32 cases in each group. Treatment group treated by XZL and 5% of sodiummorrhuateinjection under gastroscope for control group.